Home » Topics » Regulatory

Regulatory
RSS

3M submits Aldara sNDA for actinic keratosis

May 14, 2003

FDA approves revised labeling for Flonase

May 14, 2003

Adderall XR program in adolescents to extend marketing exclusivity

May 13, 2003

FDA approves new flexible dosing regimen for Lantus

May 13, 2003

Cozaar approved for diabetics with kidney disease and high blood pressure in Canada

May 12, 2003

Once-monthly octreotide acetate improves visual acuity in cystoid macular edema

May 12, 2003

Santen files NDA for levofloxacin 1.5%

May 9, 2003

Effective use of transdermal buprenorphine in cancer and noncancer pain

May 9, 2003

Vioxx approved in Canada for use in rheumatoid arthritis

May 9, 2003

New Risperdal formulation launched

May 8, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...